Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 48, pp. 84559 - 84571
The development of multidrug resistance (MDR) is one of the major challenges to the success of traditional chemotherapy treatment in cancer patients. Most...
Prevention | Pgp | MDR | Drug resistance | Pgp inhibitor | BLOCK-COPOLYMERS | X-RECEPTOR AGONIST | PHASE I/II TRIAL | PREVIOUSLY UNTREATED PATIENTS | P-GLYCOPROTEIN | CELL BIOLOGY | CELL LUNG-CANCER | IN-VITRO | OVERCOMING DRUG-RESISTANCE | GENE AMPLIFICATION | drug resistance | OVARIAN TUMOR XENOGRAFTS | prevention
Prevention | Pgp | MDR | Drug resistance | Pgp inhibitor | BLOCK-COPOLYMERS | X-RECEPTOR AGONIST | PHASE I/II TRIAL | PREVIOUSLY UNTREATED PATIENTS | P-GLYCOPROTEIN | CELL BIOLOGY | CELL LUNG-CANCER | IN-VITRO | OVERCOMING DRUG-RESISTANCE | GENE AMPLIFICATION | drug resistance | OVARIAN TUMOR XENOGRAFTS | prevention
Journal Article
Nano Research, ISSN 1998-0124, 7/2018, Volume 11, Issue 7, pp. 3619 - 3635
Multidrug resistance proteins (MDRPs), which are implicated in the mediation of multidrug resistance in tumors, represent the main obstacle to successful...
Condensed Matter Physics | Biomedicine, general | co-delivery nanoparticle | Biotechnology | multidrug resistance | Materials Science | Materials Science, general | Atomic/Molecular Structure and Spectra | legumain | doxorubicin | Nanotechnology | curcumin | PHYSICS, APPLIED | MATERIALS SCIENCE, MULTIDISCIPLINARY | CHITOSAN | CHEMISTRY, PHYSICAL | NANOSCIENCE & NANOTECHNOLOGY | HYALURONIC-ACID | BREAST-CANCER | NANOPARTICLES | IN-VITRO | OVERCOMING DRUG-RESISTANCE | MCF-7/ADR CELLS | NANOGELS | EXPRESSION | TARGETED DELIVERY | Proteins | Drug resistance in microorganisms | Anthracyclines | Chemotherapy | Biological products | Analysis | Mediation | Cancer | Toxicity | Multidrug resistance | Cytotoxicity | Drug resistance | Doxorubicin | Nuclei | Anticancer properties | Nanoparticles | Synergistic effects | Legumain | Curcumin | Inhibition | Chitosan | Tumors
Condensed Matter Physics | Biomedicine, general | co-delivery nanoparticle | Biotechnology | multidrug resistance | Materials Science | Materials Science, general | Atomic/Molecular Structure and Spectra | legumain | doxorubicin | Nanotechnology | curcumin | PHYSICS, APPLIED | MATERIALS SCIENCE, MULTIDISCIPLINARY | CHITOSAN | CHEMISTRY, PHYSICAL | NANOSCIENCE & NANOTECHNOLOGY | HYALURONIC-ACID | BREAST-CANCER | NANOPARTICLES | IN-VITRO | OVERCOMING DRUG-RESISTANCE | MCF-7/ADR CELLS | NANOGELS | EXPRESSION | TARGETED DELIVERY | Proteins | Drug resistance in microorganisms | Anthracyclines | Chemotherapy | Biological products | Analysis | Mediation | Cancer | Toxicity | Multidrug resistance | Cytotoxicity | Drug resistance | Doxorubicin | Nuclei | Anticancer properties | Nanoparticles | Synergistic effects | Legumain | Curcumin | Inhibition | Chitosan | Tumors
Journal Article
International Journal of Nanomedicine, ISSN 1176-9114, 11/2017, Volume 12, pp. 8043 - 8056
Multidrug resistance (MDR) is one of the major obstacles in successful chemotherapy. The combination of chemotherapy drugs and multidrug-resistant reversing...
Overcoming multidrug resistant | Dasatinib | Redox responsive | Co-delivery | Paclitaxel | paclitaxel | overcoming multidrug resistant | COMBINATION THERAPY | MESOPOROUS SILICA NANOPARTICLES | NANOSCIENCE & NANOTECHNOLOGY | OVARIAN-CANCER | DRUG-RESISTANCE | KINASE INHIBITOR | POLYMERIC MICELLES | ANTITUMOR-ACTIVITY | redox responsive | P-GLYCOPROTEIN | co-delivery | BREAST-CANCER | IN-VITRO | dasatinib | PHARMACOLOGY & PHARMACY | Drugs | Drug resistance in microorganisms | Drug delivery systems | Dosage and administration | Breast cancer | Research | Drug therapy | Vehicles | Medical research | Clinical trials | Glycoproteins | Kinases | Drug resistance | Cancer therapies | Ovarian cancer | Nanoparticles | Biomedical materials | Chemotherapy | Polymers | Tumors | redox-responsive
Overcoming multidrug resistant | Dasatinib | Redox responsive | Co-delivery | Paclitaxel | paclitaxel | overcoming multidrug resistant | COMBINATION THERAPY | MESOPOROUS SILICA NANOPARTICLES | NANOSCIENCE & NANOTECHNOLOGY | OVARIAN-CANCER | DRUG-RESISTANCE | KINASE INHIBITOR | POLYMERIC MICELLES | ANTITUMOR-ACTIVITY | redox responsive | P-GLYCOPROTEIN | co-delivery | BREAST-CANCER | IN-VITRO | dasatinib | PHARMACOLOGY & PHARMACY | Drugs | Drug resistance in microorganisms | Drug delivery systems | Dosage and administration | Breast cancer | Research | Drug therapy | Vehicles | Medical research | Clinical trials | Glycoproteins | Kinases | Drug resistance | Cancer therapies | Ovarian cancer | Nanoparticles | Biomedical materials | Chemotherapy | Polymers | Tumors | redox-responsive
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 05/2012, Volume 83, Issue 10, pp. 1340 - 1348
Extracellular vesicles (EVs) formed between neighbor breast cancer cells mediate ABCG2-dependent multidrug resistance (MDR) via intravesicular drug...
Extracellular vesicles (EVs) | PI3K-Akt signaling | Overcoming multidrug resistance (MDR) | Chemotherapy | ABC transporters | Breast cancer | RAT-LIVER | GEFITINIB | DRUG-RESISTANCE | LUNG-CANCER | PROTEIN BCRP/ABCG2 | TYROSINE KINASE INHIBITOR | PHARMACOLOGY & PHARMACY | FOLATE DEPRIVATION | EXPRESSION | ERLOTINIB | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Phosphorylation | Signal Transduction | Humans | Drug Resistance, Neoplasm | Phosphatidylinositol 3-Kinases - metabolism | Neoplasm Proteins - metabolism | Breast Neoplasms - drug therapy | Blotting, Western | Breast Neoplasms - metabolism | Breast Neoplasms - enzymology | Breast Neoplasms - pathology | ATP-Binding Cassette Transporters - metabolism | Cell Line, Tumor | Proto-Oncogene Proteins c-akt - metabolism | Drug resistance in microorganisms | Care and treatment | Cancer cells | Drug resistance | Cells | Cancer
Extracellular vesicles (EVs) | PI3K-Akt signaling | Overcoming multidrug resistance (MDR) | Chemotherapy | ABC transporters | Breast cancer | RAT-LIVER | GEFITINIB | DRUG-RESISTANCE | LUNG-CANCER | PROTEIN BCRP/ABCG2 | TYROSINE KINASE INHIBITOR | PHARMACOLOGY & PHARMACY | FOLATE DEPRIVATION | EXPRESSION | ERLOTINIB | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Phosphorylation | Signal Transduction | Humans | Drug Resistance, Neoplasm | Phosphatidylinositol 3-Kinases - metabolism | Neoplasm Proteins - metabolism | Breast Neoplasms - drug therapy | Blotting, Western | Breast Neoplasms - metabolism | Breast Neoplasms - enzymology | Breast Neoplasms - pathology | ATP-Binding Cassette Transporters - metabolism | Cell Line, Tumor | Proto-Oncogene Proteins c-akt - metabolism | Drug resistance in microorganisms | Care and treatment | Cancer cells | Drug resistance | Cells | Cancer
Journal Article
BIOMATERIALS SCIENCE, ISSN 2047-4830, 08/2019, Volume 7, Issue 8, pp. 3489 - 3496
Although nanodrugs have been shown to evade P-glycoprotein (P-gp) recognition and reverse multi-drug resistance (MDR) in cancer, a specific mechanism of how...
THERAPEUTICS | MATERIALS SCIENCE, BIOMATERIALS | OVERCOMING DRUG-RESISTANCE | EFFLUX PUMP | DOXORUBICIN | NANOPARTICLE DELIVERY | POLYMERIC MICELLE | ABC TRANSPORTERS | COPOLYMER MICELLES | CHEMOTHERAPY | P-GLYCOPROTEIN
THERAPEUTICS | MATERIALS SCIENCE, BIOMATERIALS | OVERCOMING DRUG-RESISTANCE | EFFLUX PUMP | DOXORUBICIN | NANOPARTICLE DELIVERY | POLYMERIC MICELLE | ABC TRANSPORTERS | COPOLYMER MICELLES | CHEMOTHERAPY | P-GLYCOPROTEIN
Journal Article
Chemical Reviews, ISSN 0009-2665, 02/2016, Volume 116, Issue 4, pp. 2602 - 2663
OVERCOMING MULTIDRUG-RESISTANCE | SELF-ASSEMBLED MICELLES | EFFICIENT INTRACELLULAR RELEASE | TARGETED DOXORUBICIN DELIVERY | BIOLOGICAL RESPONSE MODIFIERS | INTENSITY FOCUSED ULTRASOUND | IN-VITRO PROPERTIES | RING-OPENING POLYMERIZATION | PLURONIC BLOCK-COPOLYMERS | CHEMISTRY, MULTIDISCIPLINARY | NONVIRAL GENE DELIVERY | Pharmaceutical Preparations - metabolism | Nanoparticles - chemistry | Pharmaceutical Preparations - chemistry | Drug Liberation | Polymers - chemistry | Polymers - metabolism | Drug Delivery Systems
Journal Article
Chemistry of Materials, ISSN 0897-4756, 04/2016, Volume 28, Issue 7, pp. 1990 - 1993
Journal Article
ACS Applied Materials & Interfaces, ISSN 1944-8244, 06/2016, Volume 8, Issue 21, pp. 13262 - 13269
There are tremendous challenges from both tumor and its therapeutic formulations affecting the effective treatment of tumor, including tumor recurrence, and...
Research | nanodrugs | self-assembly | antitumor therapy | photodynamic therapy | codelivery | PROTEIN | MATERIALS SCIENCE, MULTIDISCIPLINARY | NANOSCIENCE & NANOTECHNOLOGY | SIRNA DELIVERY | COMBINATION | CANCER-THERAPY | NANOPARTICLES | IN-VITRO | OVERCOMING DRUG-RESISTANCE | BIOMEDICAL APPLICATIONS | MULTIDRUG-RESISTANCE
Research | nanodrugs | self-assembly | antitumor therapy | photodynamic therapy | codelivery | PROTEIN | MATERIALS SCIENCE, MULTIDISCIPLINARY | NANOSCIENCE & NANOTECHNOLOGY | SIRNA DELIVERY | COMBINATION | CANCER-THERAPY | NANOPARTICLES | IN-VITRO | OVERCOMING DRUG-RESISTANCE | BIOMEDICAL APPLICATIONS | MULTIDRUG-RESISTANCE
Journal Article
DRUG DISCOVERY TODAY, ISSN 1359-6446, 04/2017, Volume 22, Issue 4, pp. 665 - 680
The cluster-determinant 44 (CD44) receptor has a high affinity for hyaluronic acid (HA) binding and is a desirable receptor for active targeting based on its...
OVERCOMING MULTIDRUG-RESISTANCE | DRUG-DELIVERY | REDOX-SENSITIVE MICELLES | PHARMACOLOGY & PHARMACY | POLYMERIC MICELLES | MIXED MICELLES | IN-VIVO EVALUATION | COPOLYMER MICELLES | EPITHELIAL OVARIAN-CANCER | HYALURONIC-ACID | NEGATIVE BREAST-CANCER
OVERCOMING MULTIDRUG-RESISTANCE | DRUG-DELIVERY | REDOX-SENSITIVE MICELLES | PHARMACOLOGY & PHARMACY | POLYMERIC MICELLES | MIXED MICELLES | IN-VIVO EVALUATION | COPOLYMER MICELLES | EPITHELIAL OVARIAN-CANCER | HYALURONIC-ACID | NEGATIVE BREAST-CANCER
Journal Article
Drug Resistance Updates, ISSN 1368-7646, 01/2020, Volume 48, p. 100663
Journal Article
Advanced Drug Delivery Reviews, ISSN 0169-409X, 02/2017, Volume 110-111, pp. 112 - 126
Peptide–drug conjugates (PDCs) represent an important class of therapeutic agents that combine one or more drug molecules with a short peptide through a...
Peptide–drug conjugates | Conjugated chemistry | Drug delivery | Drug amphiphiles | Cancer | CANCER-CELLS | Peptide-drug conjugates | OVERCOMING MULTIDRUG-RESISTANCE | REAL-TIME ANALYSIS | MOLECULAR TRANSPORTERS | THERANOSTIC PLATINUM(IV) PRODRUG | CELLULAR UPTAKE | THERAPY IN-VIVO | AGGREGATION-INDUCED EMISSION | PHARMACOLOGY & PHARMACY | SUPRAMOLECULAR FILAMENTS | RATIONAL DESIGN | Chemotherapy | Peptides | Analysis | Transdermal medication | Medical colleges | Biomedical engineering | cancer | drug delivery | conjugated chemistry | peptide–drug conjugates | drug amphiphiles
Peptide–drug conjugates | Conjugated chemistry | Drug delivery | Drug amphiphiles | Cancer | CANCER-CELLS | Peptide-drug conjugates | OVERCOMING MULTIDRUG-RESISTANCE | REAL-TIME ANALYSIS | MOLECULAR TRANSPORTERS | THERANOSTIC PLATINUM(IV) PRODRUG | CELLULAR UPTAKE | THERAPY IN-VIVO | AGGREGATION-INDUCED EMISSION | PHARMACOLOGY & PHARMACY | SUPRAMOLECULAR FILAMENTS | RATIONAL DESIGN | Chemotherapy | Peptides | Analysis | Transdermal medication | Medical colleges | Biomedical engineering | cancer | drug delivery | conjugated chemistry | peptide–drug conjugates | drug amphiphiles
Journal Article
RSC Advances, ISSN 2046-2069, 2018, Volume 8, Issue 1, pp. 380 - 389
An effective chemotherapy is usually subject to an insufficient loading of hydrophobic drugs as well as severe side effects. In order to address these dilemmas...
Journal Article
Advanced Drug Delivery Reviews, ISSN 0169-409X, 02/2016, Volume 97, pp. 204 - 236
Hyaluronic acid (HA) is widely used in anticancer drug delivery, since it is biocompatible, biodegradable, non-toxic, and non-immunogenic; moreover, HA...
Conjugates | Drug delivery systems | Anticancer agents | Hyaluronic acid | Nanotechnology | CD44 | OVERCOMING MULTIDRUG-RESISTANCE | MOLECULAR-WEIGHT HYALURONAN | SELF-ASSEMBLED NANOPARTICLES | REDOX-SENSITIVE MICELLES | MESOPOROUS SILICA NANOPARTICLES | IN-VIVO BIODISTRIBUTION | MULTIWALLED CARBON NANOTUBES | POLYMERIC MICELLES | TUMOR-TARGETED DELIVERY | NANOSTRUCTURED LIPID CARRIERS | PHARMACOLOGY & PHARMACY | Hyaluronic Acid - administration & dosage | Humans | Hyaluronic Acid - chemistry | Drug Carriers - administration & dosage | Antineoplastic Agents - administration & dosage | Antineoplastic Agents - chemistry | Excipients - administration & dosage | Drug Carriers - chemistry | Animals | Excipients - chemistry | Nucleic Acids - chemistry | Nanostructures - administration & dosage | Hydrogels - administration & dosage | Nanostructures - chemistry | Nucleic Acids - administration & dosage | Hydrogels - chemistry | Drugs | Antimitotic agents | Nucleic acids | Antineoplastic agents | Vehicles
Conjugates | Drug delivery systems | Anticancer agents | Hyaluronic acid | Nanotechnology | CD44 | OVERCOMING MULTIDRUG-RESISTANCE | MOLECULAR-WEIGHT HYALURONAN | SELF-ASSEMBLED NANOPARTICLES | REDOX-SENSITIVE MICELLES | MESOPOROUS SILICA NANOPARTICLES | IN-VIVO BIODISTRIBUTION | MULTIWALLED CARBON NANOTUBES | POLYMERIC MICELLES | TUMOR-TARGETED DELIVERY | NANOSTRUCTURED LIPID CARRIERS | PHARMACOLOGY & PHARMACY | Hyaluronic Acid - administration & dosage | Humans | Hyaluronic Acid - chemistry | Drug Carriers - administration & dosage | Antineoplastic Agents - administration & dosage | Antineoplastic Agents - chemistry | Excipients - administration & dosage | Drug Carriers - chemistry | Animals | Excipients - chemistry | Nucleic Acids - chemistry | Nanostructures - administration & dosage | Hydrogels - administration & dosage | Nanostructures - chemistry | Nucleic Acids - administration & dosage | Hydrogels - chemistry | Drugs | Antimitotic agents | Nucleic acids | Antineoplastic agents | Vehicles
Journal Article
Advanced Materials, ISSN 0935-9648, 03/2016, Volume 28, Issue 10, pp. 1963 - 1969
A stability‐difference‐selective bond‐breakage strategy for the fabrication of largepore‐sized hollow mesoporous organosilica nanoparticles (HMONs) is...
gene delivery | cancer therapy | multidrug resistance | nanoparticles | large pores | OVERCOMING MULTIDRUG-RESISTANCE | PHYSICS, CONDENSED MATTER | PHYSICS, APPLIED | RNA | DRUG-DELIVERY | SPHERES | MATERIALS SCIENCE, MULTIDISCIPLINARY | CHEMISTRY, PHYSICAL | NANOSCIENCE & NANOTECHNOLOGY | CHEMISTRY, MULTIDISCIPLINARY | BREAST-CANCER | CO-DELIVERY | FACILE SYNTHESIS | SILICA NANOPARTICLES | BIOMEDICAL APPLICATIONS | ULTRALARGE PORES | Gene Transfer Techniques | Photoelectron Spectroscopy | Oxidation-Reduction | Humans | Oxides - chemistry | Silicon Dioxide - chemistry | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - chemistry | Drug Carriers - chemistry | Neoplasms - drug therapy | Nanotubes - chemistry | Alloys - chemistry | Metals - chemistry | Catalysis | Porosity | Antimitotic agents | Chemotherapy | Genes | Genetic aspects | Drug resistance | Antineoplastic agents | Cancer | Nanoparticles | Drug delivery systems | Strategy | Bonding | Doxorubicin | Modulators
gene delivery | cancer therapy | multidrug resistance | nanoparticles | large pores | OVERCOMING MULTIDRUG-RESISTANCE | PHYSICS, CONDENSED MATTER | PHYSICS, APPLIED | RNA | DRUG-DELIVERY | SPHERES | MATERIALS SCIENCE, MULTIDISCIPLINARY | CHEMISTRY, PHYSICAL | NANOSCIENCE & NANOTECHNOLOGY | CHEMISTRY, MULTIDISCIPLINARY | BREAST-CANCER | CO-DELIVERY | FACILE SYNTHESIS | SILICA NANOPARTICLES | BIOMEDICAL APPLICATIONS | ULTRALARGE PORES | Gene Transfer Techniques | Photoelectron Spectroscopy | Oxidation-Reduction | Humans | Oxides - chemistry | Silicon Dioxide - chemistry | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - chemistry | Drug Carriers - chemistry | Neoplasms - drug therapy | Nanotubes - chemistry | Alloys - chemistry | Metals - chemistry | Catalysis | Porosity | Antimitotic agents | Chemotherapy | Genes | Genetic aspects | Drug resistance | Antineoplastic agents | Cancer | Nanoparticles | Drug delivery systems | Strategy | Bonding | Doxorubicin | Modulators
Journal Article